Lupus erythematosus (subacute cutaneous lupus erythematosus (SCLE))

• (2012): Dalle Vedove C+, J Dtsch Dermatol Ges 10(12), 889 [REVIEW]

Periarticular thenar erythema with onycholysis syndrome

• (2017): Rodríguez-Lomba E+, Actas Dermosifiliogr 108(6), 595-597 (3 cases)

Nail disorder

• (2024): Yamamoto K+, Support Care Cancer 32(10), 647 [REVIEW]
• (2014): Prescrire Int 23(151), 180

Nail toxicity

• (2022): Morrison A+, Sci Rep 12(1), 11575

Mucositis

• (2015): Fernandes Kde A+, An Bras Dermatol 90(5), 728 (passim)

Neurotoxicity

• (2025): Moretti Rozalem N+, Biomarkers Jun, Online ahead of print [REVIEW] (pharmacogenomics)
• (2023): Zhang J+, Expert Opin Drug Saf Mar, Online ahead of print
• (2022): Guijosa A+, Clin Transl Sci Jul, Online ahead of print [REVIEW] (pharmacogenomics)

Peripheral neuropathy (sensory neuropathy / motor neuropathy)

• (2024): Mladosievicova B+, Bratisl Lek Listy 125(4), 207-210 [REVIEW] (pharmacogenomics)
• (2024): Schneider BP+, J Clin Oncol Jun, Online ahead of print
• (2021): Jablonická M+, Vnitr Lek 67(1), 26-31 [REVIEW]
• (2020): Pabst L+, Breast J Dec, Online ahead of print21% (9% grade 3)

Psychiatric adverse effect

• (2025): Lin A+, Mol Psychiatry Sep, Online ahead of print [REVIEW] (pharmacovigilance / pharmacoepidemiology)

Amenorrhea

Colitis

• (2020): Chen E+, Ann Gastroenterol 33(1), 59

Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)

• (2025): Cheng Y+, Sci Rep 15(1), 15137 [REVIEW] (pharmacovigilance / pharmacoepidemiology)

Neutropenia (neutrophils decreased)

• (2015): Fernandes Kde A+, An Bras Dermatol 90(5), 728 (passim)

Forearm swelling

• (2025): Suehiro K+, Lymphat Res Biol Sep, Online ahead of print (15 cases)

Macular edema

• (2024): Tsujinaka H+, Sci Rep 14(1), 19530
• (2013): Makri OE+, Drugs 73(8), 789 [REVIEW]

Ocular adverse effect

• (2022): Ye YT+, Front Biosci (Landmark Ed) 27(6), 171 [REVIEW]

Adverse effects / adverse reactions

• (2015): Sharma A+, Perspect Clin Res 6(2), 10917%